We are live on ! Find out more
BC

Belmont Capital Portfolio holdings

AUM $657M
1-Year Est. Return 33.14%
This Fund
S&P 500
This Quarter Est. Return
-6.22%
1 Year Est. Return
+33.14%
3 Year Est. Return
+181.86%
5 Year Est. Return
+243.64%
10 Year Est. Return
AUM
$84.8M
AUM Growth
+$2.21M
Cap. Flow
+$9.4M
Cap. Flow %
11.09%
Top 10 Hldgs %
89.74%
Holding
124
New
51
Increased
14
Reduced
8
Closed

Top Buys

Rank Stock Value
1
ABCL icon
AbCellera Biologics
ABCL
+$5.05M
2
MSFT icon
Microsoft
MSFT
+$2.01M
3
YOU icon
Clear Secure
YOU
+$1.46M
4
PFE icon
Pfizer
PFE
+$772K
5
TXN icon
Texas Instruments
TXN
+$609K

Sector Composition

Rank Sector Weight
1 Technology 36.56%
2 Communication Services 22.69%
3 Healthcare 11.14%
4 Financials 5.36%
5 Consumer Discretionary 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$24.9M 29.32%
179,859
+350
+0.2% +$54.9K
META icon
2
Meta Platforms (Facebook)
META
$1.42T
$19.1M 22.57%
141,001
+101
+0.1% +$16.4K
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$9.19M 10.84%
25,719
EFA icon
4
iShares MSCI EAFE ETF
EFA
$78B
$6.87M 8.1%
122,623
ABCL icon
5
AbCellera Biologics
ABCL
$1.74B
$5.04M 5.95%
510,000
+460,000
+920% +$5.05M
MSFT icon
6
Microsoft
MSFT
$3.45T
$3.46M 4.09%
14,874
+7,616
+105% +$2.01M
DOCS icon
7
Doximity
DOCS
$3.76B
$2.72M 3.21%
90,000
AFRM icon
8
Affirm
AFRM
$23.9B
$2.27M 2.68%
121,000
+21,000
+21% +$549K
YOU icon
9
Clear Secure
YOU
$5.57B
$1.36M 1.6%
+59,406
New +$1.46M
SOFI icon
10
SoFi Technologies
SOFI
$21B
$1.18M 1.4%
242,350
PFE icon
11
Pfizer
PFE
$143B
$696K 0.82%
+15,895
New +$772K
ROST icon
12
Ross Stores
ROST
$80.5B
$669K 0.79%
7,940
MRK icon
13
Merck
MRK
$322B
$563K 0.66%
6,532
TXN icon
14
Texas Instruments
TXN
$252B
$562K 0.66%
+3,630
New +$609K
JPM icon
15
JPMorgan Chase
JPM
$935B
$544K 0.64%
+5,204
New +$597K
SBUX icon
16
Starbucks
SBUX
$120B
$495K 0.58%
5,880
GS icon
17
Goldman Sachs
GS
$300B
$425K 0.5%
+1,449
New +$469K
ACWI icon
18
iShares MSCI ACWI ETF
ACWI
$32.9B
$360K 0.42%
4,630
-3,492
-43% -$302K
LRCX icon
19
Lam Research
LRCX
$367B
$332K 0.39%
9,070
-4,000
-31% -$178K
COMP icon
20
Compass
COMP
$8.51B
$325K 0.38%
140,000
-140,000
-50% -$497K
HON icon
21
Honeywell
HON
$77B
$322K 0.38%
+2,043
New +$356K
CL icon
22
Colgate-Palmolive
CL
$73.1B
$307K 0.36%
+4,366
New +$342K
JNJ icon
23
Johnson & Johnson
JNJ
$618B
$296K 0.35%
1,813
-15,724
-90% -$2.66M
BA icon
24
Boeing
BA
$171B
$264K 0.31%
+2,177
New +$334K
BND icon
25
Vanguard Total Bond Market
BND
$157B
$177K 0.21%
2,481
-2,454
-50% -$184K

Similar funds

Belmont Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Belmont Capital held 124 positions worth $84.8M, up 2.7% from $82.6M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Belmont Capital deployed $9.4M of net new capital in Q3 2022, opening 51 new positions and adding to 14 existing holdings. Its largest new stake was Clear Secure: 59,406 shares worth $1.36M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $2.66M trimmed.

  • Belmont Capital's largest Q3 2022 buy was Clear Secure: 59,406 shares worth $1.36M.
  • Belmont Capital added most to AbCellera Biologics in Q3 2022, an estimated $5.05M increase.
  • Belmont Capital's biggest Q3 2022 reduction was Johnson & Johnson, cutting an estimated $2.66M.
  • Belmont Capital's ten largest holdings make up 90% of its $84.8M portfolio in Q3 2022.
  • Belmont Capital opened 51 new positions and closed 0 in Q3 2022.
  • Belmont Capital's portfolio value rose 2.7% quarter-over-quarter to $84.8M.

Based on Belmont Capital's 13F filing for Q3 2022, filed 18 Oct 2022.